The ectopic study of tissue-engineered bone with hBMP-4 gene modified bone marrow stromal cells in rabbits
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 4
- DOI:
- No doi available
- Key Word:
- tissue engineering;bone morphogenetic protein;bone marrow stromal cells;gene therapy
Abstract： Background Tissue-engineering techniques combined with gene therapy have been recently reported to improve osteogenesis. In this study, tissue-engineered bone constructed by human Bone Morphogenetic Protein 4 (hBMP-4) gene-modified bone marrow stromal cells (bMSCs) was explored in an ectopic bone formation model in rabbits.Methods A pEGFP-hBMP-4 mammalian plasmid (EGFP: Enhanced Green Fluorescent Protein) was constructed by subcloning techniques. bMSCs obtained from rabbits were cultured and transfected with either pEGFP-hBMP-4, pEGFP or left uninfected in vitro. Transfer efficiency was detected through the expression of EGFP. Transcription of the target gene was detected by RT-PCR. Alkaline phosphatase (ALP) and Von Kossa tests were also conducted to explore the phenotypes of osteoblasts. The autologous bMSCs of the 3 groups were then combined with Natural Non-organic Bone (NNB), a porous hydroxyapatite implant with a dimension of 6 mm×6 mm×3 mm, at a concentration of 5×107 cells/ml. They were subsequently implanted into 6 rabbits subcutaneously using NNB alone as a blank control (6 implants per group). Four weeks after surgery, the implants were evaluated with histological staining and computerized analysis of new bone formation.Results pEGFP-hBMP-4 expression plasmid was constructed. Under optimal conditions, gene transfer efficiency reached more than 30%. Target gene transfer could strengthen the transcription of BMP-4, and increase the expression of ALP as well as the number of calcium nodules. In the ectopic animal model, NNB alone could not induce new bone formation. The new bone area formed in the bMSCs group was (17.2±7.1)%, and pEGFP group was (14.7±6.1)%, while pEGFP-hBMP-4 group was (29.5±8.2)%, which was the highest among the groups (F=7.295, P<0.01). Conclusions The mammalian hBMP-4 expression plasmid was successfully constructed and a comparatively high transfer efficiency was achieved. The gene transfer technique enhanced the expression of BMP-4 and promoted differentiation from bMSCs to osteoblasts. These in vivo results suggested that transfection of bMSCs with hBMP-4 might be a suitable method to enhance their inherent osteogenic capacity for bone tissue engineering applications.
- [1]C A, Vacanti,L J, Bonassar.An overview of tissue engineered bone.[J].1999.
- [2]Kasukawa Y,Sheng MH,Mohan S,etc.Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats.[J].2002,9(15).
- [3]Gerald R. Hankins,John Kammauff,Gregory A. Helm,etc.Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus[J].2003,5(9).
- [4]H, Petite,V, Viateau,W, Bensa?d,etc.Tissue-engineered bone regeneration.[J].2000,18(9).
- [5]Kobune M,Tsuda H,Ito Y,etc.Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector.[J].2003,7(3).
- [6]Kuznetsov SA,Mankani MH,Robey PG,etc.Repair of craniotomy defects using bone marrow stromal cells.[J].1998,66(10).
- [7]J R, Lieberman,A, Daluiski,S, Stevenson,etc.The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.[J].1999,81.
- [8]Lieberman JR,Scaduto AA.Gene therapy for osteoinduction.[J].1999,30(4).
- [9]Kloss F,Schneider H,Wiltfang J,etc.Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.[J].2003,10(13).
- [10]Rawlins B,Goshi K,Boachie-Adjei O,etc.Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone.[J].2003,28(18).
- [11]H, Yaoita,H, Orimo,Y, Shirai,etc.Expression of bone morphogenetic proteins and rat distal-less homolog genes following rat femoral fracture.[J].2000,18(2).
- [12]Peng H,Wright V,Shen HC,etc.Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.[J].2002,110(6).
- [13]Prockop DJ..Marrow Stromal Cells as Steam Cells for Nonhematopoietic Tissues[J].1997,276(5309).
- [14]Helm GA,Kallmes DF,Alden TD.Bone Morphogenetic Protein Gene Therapy.[J].2002,27(16 Suppl.1).
- [15]Hairong Peng,Shin-Tai Chen,Jon E. Wergedal,etc.Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP_4 promotes endosteal bone formation in mice[J].2004,6(1).
- [16]Sasaki T,Dumont RJ,Li H,etc.Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.[J].2003,10(20).
- [17]T W, Bauer,G F, Muschler.Bone graft materials. An overview of the basic science.[J].2000,(371).